Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 874 results found. Search for [ Oxford Covid-19 vaccine ]

Results 1 to 21 of 874
BusinessToday.In
May 17, 2021
Govt committee has completed an in-depth case review of 498 serious and severe events, of which 26 cases were reported to have potential thromboembolic events. No such events were reported after administration of Covaxin vaccine


Joe C Mathew
May 17, 2021
Since the Covid-19 vaccination drive was initiated -- more than 23,000 adverse events were reported through the CoWIN platform from 684 of the 753 districts of the country


BusinessToday.In
New Delhi, May 17, 2021
The first batch of Defence Research and Development Organisation's (DRDO) anti-COVID drug 2-DG has been released today by Defence Minister Rajnath Singh; Delhi Chief Minister Arvind Kejriwal on Sunday, May 16, extended the lockdown by one more week to curb the COVID-19 rise in the national capital; Bharat Biotech on Sunday said its COVID-19 vaccine Covaxin is effective against all new emerging variants of coronavirus, including those first found in India and UK. Watch this and more news on News Blast.BT NEWS PODCAST : Chances of hospitalisation after vaccination at 0.06% : Study


Rashi Bisaria
New Delhi, May 17, 2021
COVID-19: Chances of hospitalisation after vaccination at 0.06%, says studyAn observational study conducted by Delhi's Indraprastha Apollo Hospital has found that over 97 per cent of fully vaccinated people were protected from COVID-19 infection and the chances of hospitalisation after vaccination were only 0.06 per cent. The objective of the study was to evaluate the frequency of 'breakthrough infections'. While the study indicates that COVID-19 vaccination does not provide 100 per cent imm...


PTI
May 16, 2021
A leading UK scientist who advises the country's vaccination programme said on Saturday that vaccines being administered to protect against COVID-19 are \"almost certainly less effective\" against preventing the transmission of the B1.617.2 variant first identified in India


BusinessToday.In
New Delhi, May 14, 2021
The government panel has suggested to increase the gap between two doses of Serum Institute of India's Oxford Covid-19 vaccine 'Covishield' to 12-16 weeks for better efficacy. Currently, the interval between two doses of Covishield is four to eight weeks. No change in dosage interval for Covaxin was suggested by the panel. Those who have tested positive for Covid-19 and are waiting to take the vaccine should defer vaccination for six months after recovery, the National Technical Advisory Group on Immunisation (NTAGI) recommended. But are these suggestions backed by science? Watch the video for more details.


PTI
May 14, 2021
Referring to the latest CDC guidelines, Biden said fully vaccinated people are at a very, very low risk of contracting COVID-19


BusinessToday.In
May 13, 2021
Vaccine scarcity in many low and middle-income nations has prompted researchers and public health officials to examine strategies such as mixing two different shots


PTI
May 9, 2021
Tata Sons President (Infrastructure, Defence, Aerospace and Global Corporate Affairs) Banmali Agrawala said people need to be vaccinated faster but safely as well


Reuters
May 8, 2021
The UK has administered over 51 million vaccines and has been the second quickest country to give a first dose to at least half its adult population


PTI
May 4, 2021
COVAX urgently needs 20 million doses during the second quarter of 2021 to cover interruptions in supply triggered by increased demands for vaccines in India where COVAX's main supplier of the AstraZeneca product is based, according to WHO


BusinessToday.In
May 3, 2021
Poonawalla said SII has got 100 per cent advance of Rs 1,732.50 crore by GoI for the next tranche of 11 crore doses in the next few months.


BusinessToday.In
May 2, 2021
Earlier, Poonawalla had dropped a bombshell by saying in an interview he had extended his stay in London because of the threatening phone calls he had been receiving.


BusinessToday.In
May 1, 2021
Poonawalla said he had been getting phone calls from the \"most powerful\" in India, including chief ministers, business leaders and others for immediate supply of Covishield vaccine.


PTI
May 1, 2021
Gen Shavendra Silva, chief of COVID prevention operations, said supply is being delayed from the Serum Institute of India in the wake of the current COVID crisis in the country


Reuters
April 30, 2021
This is the first time the Anglo-Swedish drugmaker has given financial details of the distribution and sales of its vaccine, which it developed with Oxford University


PTI
April 26, 2021
Around half a million 44-year-olds will receive a text message inviting them to get their jab through the National Booking Service


BusinessToday.In
April 24, 2021
Addressing the scepticism over Covishield prices, Poonawalla said there was an inaccurate comparison between global prices of the vaccine with India, adding that it is the cheapest COVID-19 vaccine available


Reuters
April 24, 2021
Apple is one of the first large Silicon Valley companies to launch a program to help workers get vaccinated


PTI
April 24, 2021
Odds of new SARS-CoV-2 infection were reduced 65 per cent in those 21 days since first vaccination with no second dose versus unvaccinated individuals without evidence of prior infection, the Oxford University study noted


PAGES 1 OF 44  12345